130 related articles for article (PubMed ID: 22880026)
1. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
3. High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression.
Liu Y; Liu Y; Li Y; Wang T; Li B; Kong X; Li C
Head Neck; 2024 Jun; 46(6):1450-1467. PubMed ID: 38523407
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.
Gu ZY; Zhou R; Hong D; Han Y; Wang LZ; Li J; Zhang ZY; Shi CJ
Oral Dis; 2024 Apr; 30(3):1004-1017. PubMed ID: 36938639
[TBL] [Abstract][Full Text] [Related]
6. Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma.
Liu DX; Wu KH; Zang XY; Lu JY; Liu MY; Li CM; Gao L
Technol Health Care; 2024; 32(3):1473-1488. PubMed ID: 38073341
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of USP22 and Ki-67 expression in oral squamous cell carcinoma: An immunohistochemical study.
Apoorva CC; Ananthaneni A; Kumar AJ; Guduru VS; Puneeth HK
J Oral Maxillofac Pathol; 2023; 27(4):679-684. PubMed ID: 38304522
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.
Luo T; Xu T; Ou Y; Ci H; Sun J
Medicine (Baltimore); 2024 Feb; 103(7):e37278. PubMed ID: 38363884
[TBL] [Abstract][Full Text] [Related]
9. [Expression and prognostic value of IL-6 and β-catenin in oral squamous cell carcinoma].
Dong LS; Tang J; Cheng W; Ran JX; Liu ZB; Li YD
Shanghai Kou Qiang Yi Xue; 2023 Jun; 32(3):280-286. PubMed ID: 37803984
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance and Prognostic Value of SOX2 Protein Expression in Patients With Oral Squamous Cell Carcinoma.
Ghazaghi F; Saffar H; Yazdani F; Etebarian A
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):700-705. PubMed ID: 33973888
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
12. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma.
Goto Y; Sueoka E; Chiba H; Fujiki H
Jpn J Cancer Res; 1999 Dec; 90(12):1358-63. PubMed ID: 10665654
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Cytoplasmic SPNS2 Expression in Patients with Oral Squamous Cell Carcinoma.
Lu JW; Tseng YS; Lo YS; Lin YM; Yeh CM; Lin SH
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33673355
[No Abstract] [Full Text] [Related]
14. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
15. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
[TBL] [Abstract][Full Text] [Related]
16. DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity.
Leung EY; McMahon JD; McLellan DR; Syyed N; McCarthy CE; Nixon C; Orange C; Brock C; Hunter KD; Adams PD
Histopathology; 2017 Oct; 71(4):522-528. PubMed ID: 28543539
[TBL] [Abstract][Full Text] [Related]
17. High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patients.
Zhou Y; Tang Y; Luo J; Yang Y; Zang H; Ma J; Fan S; Wen Q
BMC Oral Health; 2023 Sep; 23(1):629. PubMed ID: 37661276
[TBL] [Abstract][Full Text] [Related]
18. Basal differentiation and expression status of SOX2 and KLF4 in basal layers are prognostic factors for disease-specific survival in oral squamous cell carcinoma.
Murakami K; Kamiakito T; Kawata H; Kosami K; Nakaya T; Noguchi T; Mori Y; Tanaka A
J Oral Pathol Med; 2024 May; 53(5):303-309. PubMed ID: 38659289
[TBL] [Abstract][Full Text] [Related]
19. Peptidomics-Driven Strategy Reveals Peptides and Predicted Proteases Associated With Oral Cancer Prognosis.
Neves LX; Granato DC; Busso-Lopes AF; Carnielli CM; Patroni FMS; De Rossi T; Oliveira AK; Ribeiro ACP; Brandão TB; Rodrigues AN; Lacerda PA; Uno M; Cervigne NK; Santos-Silva AR; Kowalski LP; Lopes MA; Paes Leme AF
Mol Cell Proteomics; 2021; 20():100004. PubMed ID: 33578082
[TBL] [Abstract][Full Text] [Related]
20. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for tumor stages detection and histologic grades classification of oral squamous cell carcinoma.
Xue L; Yan B; Li Y; Tan Y; Luo X; Wang M
Int J Nanomedicine; 2018; 13():4977-4986. PubMed ID: 30214201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
